The Use of Advanced Glycation End-Product Measurements to Predict Post-Operative Complications After Cardiac Surgery. [PDF]
Agrawal DS, Motta JC, Ali JM.
europepmc +1 more source
The Effect of Treatment With Aminoguanidine, an Advanced Glycation End Product Inhibitor, on Streptozotocin-Induced Diabetic Rats and Its Effects on Physiological and Renal Functions. [PDF]
Jogula RMR, Row AT, Siddiqui AH.
europepmc +1 more source
Abstract Trimethylamine N‐oxide (TMAO) is linked to arterial stiffness and atherosclerosis. Cardiovascular disease (CVD) risk increases following menopause in women. Whether menopause influences plasma TMAO metabolism to mediate CVD risk is unknown.
Daniel J. Battillo, Steven K. Malin
wiley +1 more source
Advanced glycation end-product receptor gene (RAGE) polymorphisms in patients with acute coronary syndrome - a case-control study in the Polish population. [PDF]
Gutowska K +6 more
europepmc +1 more source
Different Effects of High-Fat/High-Sucrose and High-Fructose Diets on Advanced Glycation End-Product Accumulation and on Mitochondrial Involvement in Heart and Skeletal Muscle in Mice. [PDF]
Aimaretti E +10 more
europepmc +1 more source
Advanced Glycation End Products of Maillard Reaction and Aging.
Motohiro Takeya, Kiyoshi Takahashi
openalex +2 more sources
The Receptor for Advanced Glycation End Products Is Induced by the Glycation Products Themselves and Tumor Necrosis Factor-α through Nuclear Factor-κB, and by 17β-Estradiol through Sp-1 in Human Vascular Endothelial Cells [PDF]
Nobushige Tanaka +5 more
openalex +1 more source
Abstract figure legend This graphical abstract is a schematic representation highlighting the interactions between dietary fructose, gut microbiota and ethnicity in shaping metabolic health. Abstract Important health disparities are observed in the prevalence of obesity and associated non‐communicable diseases (NCDs), including type 2 diabetes (T2D ...
Florine H.M. Westerbeke +3 more
wiley +1 more source

